Key words: FRP/vimentin/actomyosin ABSTRACT. Fusion regulatory proteins (FRPs) regulate virus-mediated cell fusion and multinucleated giant cell formation of monocytes. Anti-FRP-1 mAbsimmunoprecipitated 80 kDa and 38 kDa proteins from HeLa cells. After long exposure other bands were detected, suggesting the presence of molecule(s) associated with FRP-1. To identify the molecule(s), we prepared monoclonal antibodies against immunoaffinity-purified FRP-1 complex derived from membranefractions of HeLa cells. Immunofluorescence microscopy revealed that these monoclonal antibodies recognized the intracytoplasmic molecules in HeLa cells. Using immunoblotting, the antibodies reacted with 200 kDa, 70 kDa, 55 kDa and 35 kDa molecules, so we designated these molecules as FRPrelated molecules (FRMs). Subsequently, we performed gene cloning from a HeLa^gtll CDNAlibrary using anti-FRM mAbsand immunoblotting analysis with either purified cytoskeletal proteins or specific antibodies against various cytoskeletal proteins. Three kinds of positive clone were obtained, which encoded partial sequences of vimentin, tropomyosin, and heat shock cognate protein 70 (hsc70). The 200 kDa molecule was expected to be a myosin heavy chain, judging from the immunoblotting pattern. Immunoblotting confirmed that these purified proteins were readily recognized by anti-FRM mAbs. Furthermore, anti-vimentin and anti-myosin mAbs reacted with the precipitates by anti-FRP-1 mAb, indicating a physical association between FRP-1 molecules and these cytoskeletal proteins. Whenanti-FRP-1 mAbwas added to culture fluids of HeLa cells, the cellshape and immunofluorescence-pattern stained with anti-FRM mAbschanged. Taken together, the fusion regulatory molecular complex is suggested to consist of at least FRP-1, hsc70, actomyosin and vimentin systems.
Membrane fusion is an important event in biologic phenomena. For fertilization, sperm fuse with the plasmamembraneof an egg (1). Myogenesis, osteogenesis, exo-and endocytosis, organelle formation and intracellular organelle traffic are also related to membrane fusion. However, the regulatory mechanisms of membrane fusion are not well understood. Wehave recently isolated monoclonal antibodies (mAbs) which regulate cell fusion induced by viruses including Newcastle disease virus, measles virus and HIV (16, 21) and multinucleated giant cell formation of monocytes (26) . These mAbs immunoprecipitated gp80 and gpl35, which were detected on the surface of HeLa and U937cells. These molecules were designated as fusion regulatory protein (FRP)-l and -2, respectively.
In our previous study, FRP-1 and -2 were found to be heavy chains of CD98/4F2 (20) and integrin «3 (21) , reTo whomcorrespondence to be addressed.
spectively. The integrins are a family of transmembrane glycoproteins, which interact with a variety of ligands including extracellular matrix glycoproteins, complement and other cells (10, ll, 27) . CD98 is a disuMdelinked heterodimer and is expressed on monocytesand activated T and B cells (7) but the functions of the molecule remain unclear.
We have reported that FRP-1 and FRP-2 systems exist separately from each other and have their own signal transduction pathways (21) . In addition, FRPs-mediated cell fusion was cytoskeleton dependent, suggesting a possibility of an association between FRPs and cytoskeletal components (21) . The integrin cytoplasmic domains have been shown to interact with actin filament via talin, vinculin, a-actinin (3, 8, 29) . On the other hand, to our knowledge, intracellular components which interact with FRP-1/CD98 molecules have not been examined. In the present study, we searched for FRP-1-related molecules (FRMs) to clarify a mecha-nism of FRP-1-mediated cell fusion. We found that immunoprecipitation of HeLa cells by anti-FRP-1 mAbrevealed the presence of FRMs. Monoclonal antibodies against immunoaffinity-purified FRP-1 complex were shown to recognize intracellular molecules, which were different from each other in their size and distribution. Further analysis of FRMsby using these mAbsidentified them as vimentin, tropomyosin, myosin and hsc70. Intriguingly, we showed that the rearrangement of FRMsoccurred when anti-FRP-1 mAbwas added to the culture mediumof HeLacells.
MATERIALS AND METHODS
Cells. HeLa cells and Humanembryonic fibroblast (HEF) were cultured in Eagle's minimumessential medium (MEM) supplemented with 5%fetal calf serum.
Antibodies. Anti-FRP-1 mAb (mAb 4-5-1) has been previously described (16 Amersham (Tokyo, Japan). Anti-human parainfluenza 4A virus NP mAb(3B) was used as the control antibody. Isotopic labeling, RIPA and SDS-PAGE.Isotopic labeling of HeLacells, radio-immunoprecipitation assay (RIPA), and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were done as described previously (14). Western blotting. HEFlysate or purified cytoskeletal proteins were run on 10%SDS-PAGE and electroblotted on a polyvinylidine difluoride (PVDF) membrane. The blotted PVDFmembrane was blocked with 5% non-fat milk in PBS containing 0.05% Tween-20 (PBST) for 1 hour and then cut into strips and incubated for 1 hour in primary antibodies. After washing for 30 minutes in PBST, the strips were incubated for 1 hour with biotinylated secondary antibody. The strips were washed as just described and incubated for 30 minutes in ABCsolution (1/100 dilution of avidin and biotinylated HRP, Vector Laboratories, Inc. Burlingame, CA).
Bound antibodies were visualized using 4-chloro-l-naphthol or ECL Western blotting detection kit (Amersham). Purified vimentin from bovine lens, myosin from rabbit muscle, tropomyosin from chicken gizzard and hsp70 from bovine brain were purchased from Sigma Chemical Co. Dot blotting. One fig of purified vimentin or myosin was dotted onto nitrocellulose membrane. Themembrane was processed as in Western blotting to visualize the specific binding of mAbwith the dotted proteins.
Purification ofFRP-1 complex. Plasma membraneswere prepared from HeLa cells (2 x 109) by the method of Maeda et al. (19) . The cell membranes were solubilized with 30 ml of 50 mMTris-HCl, 1% Triton X-100 using an ultrasonic cell disruptor and centrifuged at 25,000 g for 20 minutes. The supernatant was passed through Sepharose 4B and control IgG (anti-parainfluenza virus type 4A mAb)column to remove nonspecifically adhering materials. The flow-through fraction was applied to an mAb4-5-1 immunoafnnity column and the columns were washed free of unbound proteins with 10 volumes of solubilized buffer. The bound protein was sequentially eluted stepwise with LiCl in 50 mMTris-HCl (pH 7.5). The LiCl eluate was dialyzed against NANOpure water and concentrated by using a speedvac concentrator. Production and isolation ofhybridoma cell lines. The procedures used for preparation of mAbswere similar to the method described previously (28) . In brief, three mice were immunized with purified FRP-1 complex and their spleen cells were fused with SP2/0-Ag-14 myeloma cells. The culture fluids of hybridoma cells were screened by enzyme-linked immunosorbent assay (ELISA). Cultures of interest were then cloned by soft-agar colony formation and further cloned by limiting dilution.
Enzyme-linked immunosorbent assay (ELISA). ELISA was performed as described previously (22) HeLa igtl l CDNAlibrary was obtained from Clontech Laboratories (Palo Alto, CA). The clones were immunoscreened using anti-FRM mAbsaccording to the manufacturer's protocol (Clontech Laboratories). Positive clones were subcloned into pBluescript II SK(-) and sequenced by the dideoxy chain termination method (Sanger et al., 1977) . Nucleotide and amino acid sequence analyses were aided by GENETYX-MAC/CD computer programs (Software Development, Tokyo, Japan).
Indirect immunofluorescence. HeLa cells were fixed with 3% formalin, treated with 0.05% Triton X-100, and stained with hybridoma supernatant or purified antibody and FITC- Production and characterization of mAbsagainst immuno-affinity-purified FRP-1 complex. Weraised monoclonal antibodies against purified FRP-1 complex described above. ElevenmAbs (mAb 3, 8, 9, ll, 12, 14, 16, 17, 24, 57 and 124) were obtained, and then characterized by immunoblotting and indirect immunofluorescence. Immunoblotting of these mAbsusing HEFlysate revealed reactivity with specific bands (Fig. 4A) . The mAbs 8, 9, ll, 12, 14, 17, 24, 57 and 124recognizedthe 55 kDa molecule (Fig. 4A , lane 2 and data not shown). Subsequently, indirect immunofluorescence was performed using these antibodies. As shown in Fig. 5 , although staining patterns varied, each antibody recognized intracytoplasmic components, not cell surface proteins. WhenHeLa cells were fixed and immunostained with the mAb3, fine granular structures were diffusely stained (Fig. 5A) . Using the mAbs which recognize the 55 kDa molecule, filamentous structures, resembling the cytoskeleton, were stained (Fig. 5B) . The mAbs16 and 57 stained fine granular structures. Unlike the mAb 3, the fine granular structures mainly colocalized with actin filaments (Fig. 5C , D, E, F). As summarized in Table I , the mAbsrecognized FRP-1-related molecules (FRMs), and FRMsconsisted of at least four molecules differing in size and intracellular localization.
Furthermore, immunofluorescence staining suggested some FRMscould be cytoskeletal or cytoskeleton-associated proteins.
Isolation and sequencing of CDNAencoding FRMs. Using anti-FRM mAbs, we screened about 1x105 plaques from a HeLa igtll CDNAlibrary and cloned three kinds of positive phage recombinant, that is, F3 (271 bp) was reacted with mAb3; F39 (383 bp) was reacted with mAbs 12, 17, 57 and 124; F57 (1,000 bp) was reacted with mAb57. The inserts were subcloned into with the 55 kDa vimentin band (Fig. 7 and data not shown). Anti-FRM mAb57 showed cross-reactivity with tropomyosin and myosin, which was recognized by anti-FRM mAb16, and anti-FRM mAb3 recognized purified hsc70 (Fig. 7) . These results showed that FRMs consist of vimentin, hsc70, and myosin. As to tropomyosin, because of the cross-reactivity of anti-FRM mAb57, the possibility remained that the protein was not really one of the FRMs. To exclude the possibility, ELISA using purified FRP-1 complex and ai^ti-tropomyosin mAbwas done. Anti-tropomyosin mAbreacted with the purified FRP-1 complex, suggesting that tropomyosin is certainly contained in the complex (data not shown). In addition, anti-hsc70, -vimentin and -myosin mAbs also reacted with the purified FRP-1 complex in ELISA (data not shown). Coprecipitation ofFRMs with antiFRP-1 mAb. To confirm the physical association between FRP-1 and FRMs,we immunoprecipitated the membranefraction of HeLa cells with anti-FRP-1 mAband then probed 
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terns stained by anti-FRM mAbswhich recognized vimentin (Fig. 9E, F, G, H) . The filamentous stains were no longer present, but fine granules and some spheroidal bodies were stained. No other anti-FRM mAbs showed any significant change by anti-FRP-1 mAbtreatment. Microtubules and micro filaments also retained the original structures throughout the observation (data not shown).
DISCUSSION
Wehave recently reported that cytochalasin B (antimicrofilament agent) completely blocks the cell agglutination and cell fusion of U2ME-7cells induced by anti-FRP-1 mAb. Intriguingly, cytochalasin B inhibits the cell fusion whenever it is added during incubation (even after cell agglutination has already taken place), although existing cell agglutination is not loosened by cytochalasin B. In addition, vinblastine (anti-microtubules agent) inhibits FRP-1 -mediated polykaryocyte formation of U2ME-7cells, but has no effect on cell agglutination. These findings indicated that FRP-1-mediated cell fusion is cytoskeleton dependent and that there is the possibility of an association between FRP-1 molecule and cytoskeletal components.
In the present study, we have shown that FRP-1mole-cules are associated with cytoskeletal components, including vimentin, tropomyosin, myosin and hsc70. Vimentin is one of the intermediate filaments (IFs), which is relatively well characterized in terms of its molecular structure and conformation (24, 25) . mediate an association between the plasma membrane glycoprotein and the cell cytoskeleton (9). Hsc70 was shown in Dictiostelium to affect actin polymerization through interacting with cap32/34, actin capping proteins (6). Therefore, hsc70 could act as one of the FRMs through connecting vimentin and/or actin to FRP-1. Taken together, the experimental data which support the physical association between FRP-1 and FRMsare as follows: (1) The immunoafnnity purified material actually contained FRP-1, while comparable amounts of any other molecules were not present. (2) Anti-FRM mAbs, which were raised against the FRP-1 complex, recognized vimentin, myosin, tropomyosin and hsc70. Some questions against our data may be raised. As to why the affinity-purified FRP-1 complex elicited anti-FRP-1 mAbs, we can conjecture that FRP-1 may be too quickly lost its immunogenicity in LiCl solution to elicit the antibodies, although it has dialyzed against NANOpurewater soon after the elution. ELISA data that affinity-purified FRP-1 did not react with anti-FRP-1 mAbin a short time after the purification suggested the antigenic unstability of FRP-1 (data not shown). As to why did not successfully coprecipitate It has been reported that phosphorylation of vimentin by A kinase, C kinase or p34cdc2 induces disassembly of the filament structure (4, 12, 13). In our previous study, anti-FRP-1 mAb-induced cell fusion is inhibited by both C kinase inhibitor (21) and A kinase inhibitor (unpublished data). From these data, we could speculate that the phosphorylation of vimentin followed by its disassembly is involved in anti-FRP-1 mAbinduced cell fusion.
In summary, wehave found that there are at least two fusion regulatory systems, FRP-1 and FRP-2 systems. FRP-2 system is the integrin systems as previously reported (21) . It is well-known that integrins are associated with cytoskeletal components through some molecules such as talin, vinculin and a-actinin. The FRP-1 system is found to consist of FRP-1/CD98 molecule and other intracytoplasmic component such as hsc70, IF and actomyosin. Therefore, it is inferred that the outside-in signals produced by the interaction of FRP-1/CD98 molecules with anti-FRP-1 mAbis transmitted via these molecules and other cytoskeletal components.
